Can nirmatrelvir/ritonavir treatment shorten the duration of COVID-19 isolation?

BACKGROUND: The impact of nirmatrelvir/ritonavir treatment on shedding of viable virus in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unclear. METHODS: A prospective cohort study evaluating mildly ill COVID-19 patients was conducted. Virologic responses were compared between nirm...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Haein, Yang, Jeong-Sun, Ko, Jae-Hoon, Lee, Myungsun, Lee, Joo-Yeon, Park, Sehee, Kim, Jun-Won, Shin, Younmin, Lee, Jung-Min, Na, Yoo Jin, Park, Byoung Kwon, Kim, Hyungjin, Lee, Young Ho, Yang, Jinyoung, Huh, Kyungmin, Cho, Sun Young, Kang, Cheol-In, Chung, Doo Ryeon, Peck, Kyong Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596971/
https://www.ncbi.nlm.nih.gov/pubmed/36314031
http://dx.doi.org/10.3389/fmed.2022.988559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596971/
https://www.ncbi.nlm.nih.gov/pubmed/36314031
http://dx.doi.org/10.3389/fmed.2022.988559

Ejemplares similares